1,615 reports of this reaction
3.8% of all SOLIFENACIN SUCCINATE reports
#2 most reported adverse reaction
DRY MOUTH is the #2 most commonly reported adverse reaction for SOLIFENACIN SUCCINATE, manufactured by Astellas Pharma US, Inc.. There are 1,615 FDA adverse event reports linking SOLIFENACIN SUCCINATE to DRY MOUTH. This represents approximately 3.8% of all 42,941 adverse event reports for this drug.
Patients taking SOLIFENACIN SUCCINATE who experience dry mouth should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRY MOUTH is moderately reported among SOLIFENACIN SUCCINATE users, representing a notable but not dominant share of adverse events.
In addition to dry mouth, the following adverse reactions have been reported for SOLIFENACIN SUCCINATE:
The following drugs have also been linked to dry mouth in FDA adverse event reports:
DRY MOUTH has been reported as an adverse event in 1,615 FDA reports for SOLIFENACIN SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRY MOUTH accounts for approximately 3.8% of all adverse event reports for SOLIFENACIN SUCCINATE, making it one of the most commonly reported side effect.
If you experience dry mouth while taking SOLIFENACIN SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.